Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of IL-23 in SLE-related ILD
NCT06713187Recruiting
- Sponsor
- Sohag University
- Start
- May 2025
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Sohag University. Primary endpoint: Serum Interleukin-23 Level at 2 years. Started May 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06713187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06713187.